VALLEY FORGE, Pa.--(BUSINESS WIRE)--Nov. 28,
2007--AmerisourceBergen Corporation (NYSE:ABC) today filed its Annual
Report on Form 10-K for the fiscal year ended September 30, 2007 with
the Securities and Exchange Commission.
AmerisourceBergen makes available, free of charge via its website,
all Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q,
Current Reports on Form 8-K and other information filed with or
furnished to the SEC, including amendments to such reports. This
information is available under the investors section at
www.amerisourcebergen.com as soon as reasonably practicable after it
is electronically filed with the SEC. In addition, the SEC maintains a
website at www.sec.gov that contains AmerisourceBergen information
filed electronically with them.
Alternatively, stockholders may receive a hard copy of the Annual
Report on Form 10-K, free of charge upon request. A written request
should be sent to Stockholder Relations, AmerisourceBergen
Corporation, P.O. Box 959, Valley Forge, PA 19482.
About AmerisourceBergen
AmerisourceBergen is one of the world's largest pharmaceutical
services companies serving the United States, Canada and selected
global markets. Servicing both pharmaceutical manufacturers and
healthcare providers in the pharmaceutical supply channel, the Company
provides drug distribution and related services designed to reduce
costs and improve patient outcomes. AmerisourceBergen's service
solutions range from pharmacy automation and pharmaceutical packaging
to reimbursement and pharmaceutical consulting services. With more
than $66 billion in annual revenue, AmerisourceBergen is headquartered
in Valley Forge, PA, and employs more than 11,500 people.
AmerisourceBergen is ranked #29 on the Fortune 500 list. For more
information, go to www.amerisourcebergen.com.
Forward-Looking Statements
This news release may contain certain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements
are based on management's current expectations and are subject to
uncertainty and changes in circumstances. Actual results may vary
materially from the expectations contained in the forward-looking
statements. The following factors, among others, could cause actual
results to differ materially from those described in any
forward-looking statements: competitive pressures; the loss of one or
more key customer or supplier relationships; customer defaults or
insolvencies; changes in customer mix; supplier defaults or
insolvencies; changes in pharmaceutical manufacturers' pricing and
distribution policies or practices; adverse resolution of any contract
or other disputes with customers (including departments and agencies
of the U.S. Government) or suppliers; regulatory changes (including
increased government regulation of the pharmaceutical supply channel);
government enforcement initiatives (including (i) the imposition of
increased obligations upon pharmaceutical distributors to detect and
prevent suspicious orders of controlled substances (ii) the
commencement of further administrative actions by the U. S. Drug
Enforcement Administration seeking to suspend or revoke the license of
any of the Company's distribution facilities to distribute controlled
substances, or (iii) the commencement of any enforcement actions by
any U.S. Attorney alleging violation of laws and regulations regarding
diversion of controlled substances and suspicious order monitoring);
changes in U.S. government policies (including reimbursement changes
arising from federal legislation, including the Medicare Modernization
Act and the Deficit Reduction Act of 2005); changes in regulatory or
clinical medical guidelines and/or reimbursement practices for the
pharmaceuticals we distribute, including erythropoiesis-stimulating
agents (ESAs) used to treat anemia patients; price inflation in
branded pharmaceuticals and price deflation in generics; the inability
of the Company to successfully complete any transaction that the
Company may wish to pursue from time to time; fluctuations in market
interest rates; operational or control issues arising from the
Company's outsourcing of information technology activities; success of
integration, restructuring or systems initiatives; fluctuations in the
U.S. dollar - Canadian dollar exchange rate and other foreign exchange
rates; economic, business, competitive and/or regulatory developments
in Canada, the United Kingdom and elsewhere outside of the United
States; acquisition of businesses that do not perform as we expect or
that are difficult for us to integrate or control; any operating
problems and/or cost overruns that may be associated with the
implementation of an enterprise resource planning system; changes in
tax legislation or adverse resolution of challenges to our tax
positions; and other economic, business, competitive, legal, tax,
regulatory and/or operational factors affecting the business of the
Company generally. Certain additional factors that management believes
could cause actual outcomes and results to differ materially from
those described in forward-looking statements are set forth (i) in
Item 1A (Risk Factors) in the Company's Annual Report on Form 10-K for
the fiscal year ended September 30, 2007 and elsewhere in that report
and (ii) in other reports filed by the Company pursuant to the
Securities Exchange Act of 1934.
CONTACT: AmerisourceBergen Corporation
Michael N. Kilpatric
610-727-7118
mkilpatric@amerisourcebergen.com
SOURCE: AmerisourceBergen Corporation